TY  - GEN
AU  - Vogelson,Cullen T
AU  - Abelson,Mark B
AU  - Pasquine,Terri
AU  - Stephens,Donna M
AU  - Gamache,Daniel A
AU  - Gross,Robert D
AU  - Robertson,Stella M
AU  - Yanni,John M
TI  - Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration
SN  - 1088-5412
PY  - 2004///0423
KW  - Administration, Topical
KW  - Adult
KW  - Aged
KW  - Allergens
KW  - adverse effects
KW  - Animals
KW  - Anti-Allergic Agents
KW  - administration & dosage
KW  - Capillary Permeability
KW  - drug effects
KW  - Circadian Rhythm
KW  - Conjunctivitis, Allergic
KW  - drug therapy
KW  - Dibenzoxepins
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Guinea Pigs
KW  - Histamine H1 Antagonists
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Olopatadine Hydrochloride
KW  - Ophthalmic Solutions
KW  - Severity of Illness Index
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
ER  -